Fed up with Ads? Install Dainik Bhaskar app for news without ads
New Delhi20 hours ago
- Copy link
Since the vaccination began on 16 January, more than 7.5 million doses of Kovishield and Kovaxin have been given in India. (Symbolic image)
Randeep Guleria, director of the All India Institute of Medical Sciences (AIIMS) Delhi, said that antibodies against the corona can persist for 8 months or longer after the vaccine is applied. He said that scientists are working fast for long-term security. He hoped that vaccination for people over 50 years of age could begin in March. Guleria, a member of the National Task Force on Corona, also answered several questions on social media.
Antibody will develop after 14 days
He said that the antibody would develop about 14 days after the second shot. It is not clear how long this protection will last, but it is assumed that it will be effective for at least 8 months or longer. Since the vaccination began on 16 January, more than 7.5 million doses of Kovishield and Kovaxin have been given in India.
Veterinarians are not a priority
Guleria said that the population above 50 years of age will start receiving the vaccine from March 2021. He also said that it would also include an already ill population between 20 and 50 years old. On the question of why veterinarians are not included in the list of high-risk workers, he said that this is because they are not treating Corona patients.
People suffering from serious diseases will also get vaccine
Guleria said that people with more serious diseases will get the vaccine on an age basis. Why is the government depriving people of their own by supplying vaccines to other countries? To this question, Guleria said that since people travel and become carriers of the virus, everyone should be vaccinated globally to control the spread. Therefore, all countries need to get their share of vaccines.